Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Key proteins linked to brain tumor growth offer hope for personalized therapies

  • medicalxpress.com language
  • 2025-06-26 03:47 event
  • 2 months ago schedule
Key proteins linked to brain tumor growth offer hope for personalized therapies
Researchers from the University of Plymouth have identified proteins that fuel the growth of the most common type of brain tumor, a discovery that could ultimately lead to less invasive treatments for patients.

2.975. In sub-Saharan Africa, 1 in 6 cancer medications found to be defective

  • 2 months ago schedule
  • medicalxpress.com language

Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.

2.976. Where a very preterm baby is born may affect survival odds and hospital time

  • 2 months ago schedule
  • medicalxpress.com language

Nearly one in every 10 infants in the United States is born preterm, or before 37 weeks of gestational age, according to the Centers for Disease Control and Prevention. Infants born with very low birthweights—under 3.3 pounds at birth—are disproportionately very preterm—29-weeks gestation or earlier. These infants make up 1% of births, but account for more than half of infant deaths in the United States each year. The mortality rate for infants born very preterm, and length of hospital stay, may vary across health systems, according to a new study by researchers at Penn State.

2.977. Protein split reveals dual roles in childhood ciliopathies and cell signaling

  • 2 months ago schedule
  • medicalxpress.com language

New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, Joubert syndrome and other ciliopathies is cut in half to perform two separate functions, both of which are fundamental to the healthy development of children.

2.978. Monthly obesity shot shows big weight loss in trial

  • 2 months ago schedule
  • medicalxpress.com language

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body weight over a year, researchers reported Monday in The New England Journal of Medicine.

2.979. Insurers promise to speed up delays in health care approvals

  • 2 months ago schedule
  • medicalxpress.com language

Getting approval from your insurance company before a procedure or treatment may soon get a little easier.

2.980. Texas governor blocks THC ban, keeping gummies and vapes legal

  • 2 months ago schedule
  • medicalxpress.com language

THC-infused gummies and vape pens will stay legal in Texas—at least for now.

2.981. The protein agrin is essential for balancing bone tissue, research finds

  • 2 months ago schedule
  • medicalxpress.com language

A recent discovery could transform our understanding of bone health maintenance and pave the way for potential treatments for bone diseases, including osteoporosis. Researchers at the University of São Paulo's Ribeirão Preto School of Dentistry (FORP-USP) in Brazil have identified a protein called agrin that plays an essential role in preserving bone mass and quality.

2.982. Olympians' hearts in focus: Study reveals elite rowers' surprising AFib risk

  • 2 months ago schedule
  • medicalxpress.com language

A new study involving 121 former elite rowers from Australia has revealed one in five develops atrial fibrillation (AFib).

2.983. Tackling depressive symptoms in high school students by honing emotional and social skills

  • 2 months ago schedule
  • medicalxpress.com language

Today, high school students worldwide face unprecedented levels of stress as they navigate academic pressures, issues with social identity, and future career decisions.

2.984. Key proteins linked to brain tumor growth offer hope for personalized therapies

  • 2 months ago schedule
  • medicalxpress.com language

Researchers from the University of Plymouth have identified proteins that fuel the growth of the most common type of brain tumor, a discovery that could ultimately lead to less invasive treatments for patients.

2.985. Why there's a growing backlash against plant-based diets

  • 2 months ago schedule
  • medicalxpress.com language

People in the UK are eating too much meat—especially processed meat—according to a recent report from the Food Foundation, a UK charity.

2.986. Role of tumor microenvironment in nasopharyngeal carcinoma progression uncovered

  • 2 months ago schedule
  • medicalxpress.com language

A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor immune microenvironment (TIME) plays a critical role in the progression of nasopharyngeal carcinoma (NPC) commonly known as nose cancer. These insights are paving the way for precision oncology approaches, some of which are currently used in clinical trials at NCCS. The findings are published in Cell Reports Medicine.

2.987. Liver organoid generates organ-specific blood vessels for the first time

  • 2 months ago schedule
  • medicalxpress.com language

Scientists from Cincinnati Children's and colleagues based in Japan report achieving a major step forward in organoid technology: producing liver tissue that grows its own internal blood vessels.

2.988. Researchers develop high-performance, open-source AI for breast cancer detection

  • 2 months ago schedule
  • medicalxpress.com language

In a major breakthrough, a team of researchers from The City College of New York and Memorial Sloan Kettering Cancer Center (MSKCC) has developed a new AI model that can detect breast cancer in MRI images and pinpoint the location of tumors.

2.989. AI-assisted model enhances low-quality MRI heart scans

  • 2 months ago schedule
  • medicalxpress.com language

An AI-assisted model developed by researchers from the University of Missouri School of Medicine and the School of Engineering can take low-quality MRI heart scans and turn them into high-quality images, while reducing the time needed to scan the heart by about 90%.

2.990. Common medicine for autoimmune diseases works on giant cell arteritis

  • 2 months ago schedule
  • medicalxpress.com language

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of Medicine at the University of Pennsylvania published in the New England Journal of Medicine.

2.991. Living in more disadvantaged neighborhoods may increase risk of inflammation and dementia biomarkers

  • 2 months ago schedule
  • medicalxpress.com language

People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer's disease, according to a study published in Neurology. The study does not prove that neighborhood factors cause these biomarkers: it only shows an association.

2.992. Gene therapy may be key to permanently putting HIV into dormant state

  • 2 months ago schedule
  • medicalxpress.com language

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a molecule within HIV itself can be manipulated and amplified to force the virus into long-term dormancy, a state in which HIV does not replicate.

2.993. Study finds vitamin C boosts skin thickness by reactivating growth genes

  • 2 months ago schedule
  • medicalxpress.com language

The skin acts as the body's first line of defense against external threats. However, as we age, the epidermis—the outermost layer of skin—gradually becomes thinner and loses its protective strength. About 90% of the cells in this layer are keratinocytes, which originate from deeper layers of the epidermis and migrate upward, ultimately forming the skin's protective barrier.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.